A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT06602219 · COMPLETED
Trial details
- NCT number
- NCT06602219
- Sponsor
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-25
- Primary completion
- 2025-07-24
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.